GRAL - GRAIL Inc.
About GRAIL Inc. (http://www.grail.com)
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, its precision oncology portfolio consists of n RUO-targeted methylation-based platform that enables applications for disease prognostication, risk stratification, minimal residual disease detection, and recurrence and relapse monitoring. The company was incorporated in 2015 and is headquartered in Menlo Park, California.
Key Executives
| NAME | TITLE | DOB | SALARY |
|---|---|---|---|
| Robert Ragusa | Advisor | 1960 | $1,616,399 USD |
| Aaron Freidin | CFO & Head of Corporate Development | 1979 | $1,134,942 USD |
| Joshua J. Ofman | Chief Executive Officer & Director | 1965 | $1,123,985 USD |
| Abram Barth | Chief Legal Officer & Corporate Secretary | – | – |
| Alexis Tosti | Vice President of Strategy & Corporate Development | – | – |
| Alison Highlander | Chief People Officer | – | – |
| Andrew John Partridge | Chief Growth Officer | 1969 | – |
| Eric T. Fung | Senior Vice President of Clinical Development | 1970 | – |
| Erin Polak | Senior Vice President of Government Affairs, Policy, and Alliance Development | – | – |
| Paul Ciccolella | Senior Vice President of Global Development & Operations | – | – |
| Satnam Alag | Chief Technology Officer | – | – |
| Sir Harpal S. Kumar | Chief Scientific Officer and President of Global Clinical & Medical Affairs | – | – |
| Trish Rowland | Senior Vice President of Corporate Communications | – | – |